Skip to main content
. 2021 Mar 26;39(18):2517–2525. doi: 10.1016/j.vaccine.2021.03.076

Table 1.

Distribution by gender and number of comorbidities according to age class (ATS of Milan, 2021).

16–64
65–79
80+
Total
N. deaths/N. cases % OR (95% CI) N. deaths/N. cases % OR (95% CI) N. deaths/N. cases % OR (95% CI)
Gender
 Females 202/59,256 0.34 1# 815/8,969 9.09 1# 1,857/5,873 31.62 1# 74,098
 Males 491/55,859 0.88 2.49   (2.11–2.94) 1967/10,885 18.07 2.20 (2.01–2.40) 2,335/5,245 44.52 1.91 (1.76–2.07) 71,989
N. of comorbidities
 0 215/84,193 0.26 1# 386/4,442 8.69 1# 434/1,347 32.2 1# 89,982
 1 166/21,241 0.78 1.62  (1.31–1.99) 631/5,845 10.80 1.11 (0.97–1.27) 1,006/2,866 35.1 1.13 (0.98–1.30) 29,952
 2–3 211/8,405 2.51 3.95  (3.23–4.84) 1,036/6,922 14.97 1.48 (1.30–1.68) 1,720/4,665 36.9 1.20 (1.05–1.37) 19,992
 4+ 101/1,175 7.92 11.01 (8.52–14.23) 729/2,645 27.56 2.93 (2.55–3.37) 1,032/2,240 46.1 1.76 (1.52–2.04) 6,161
Total 693/115,115 2,782/19,854 4,192/11,118 146,087